Metabolic Effects of Psychotropic Drugs
Editor(s): Thakore J. (Dublin)
Leonard B.E. (Galway)
Publication year: 2009
|Buy this book|
|Digital Version:||CHF 96.00, EUR 90.00, USD 113.00|
|Print Version:||CHF 96.00, EUR 90.00, USD 113.00|
|The final prices may differ from the prices shown due to specifics of VAT rules, postage and handling.|
|Order this title|
You already have online access to this title. If you would like to buy a personal digital or print copy, please click here.
Modern Trends in Pharmacopsychiatry , Vol. 26
Editor(s): Leonard B.E. (Galway)
VIII + 134 p., 6 fig., 11 tab., hard cover, 2009
This book brings together reviews that help put into context exactly why subjects with SMI develop obesity, prediabetic status, overt type 2 diabetes mellitus and related cardiovascular events. The relationship between prolactin and bone mineral density in subjects under medical treatment and the underlying dopaminergic mechanisms as well as the immunological changes occurring as an integral part of SMI and their effects on endocrine function are discussed and reviewed.
Psychiatrists, diabetologists, cardiologists, family practitioners, public health physicians as well as basic science researchers will find valuable guidelines when screening for type 2 diabetes mellitus and cardiovascular disease in SMI.